StockData

MiMedx vs SkinHealth Systems

MDXG and SKIN side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MDXG and SKIN compare

SkinHealth Systems is the larger company, worth 3.9 times as much as MiMedx ($1.8B against $464M).

SkinHealth Systems grew revenue faster over the last twelve months (−6.5% versus −22.8% for MiMedx).

MiMedx keeps more of each dollar of sales as profit, with a net margin of −6.3% compared with −9.8% at SkinHealth Systems.

MiMedx scores higher on the StockData Score (12 against 4 for SkinHealth Systems), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMDXGSKIN
Size and price
Market cap$464M$1.8B
Share price$3.18$13.88
Change, 1 year−56.9%−45.8%
Change, 5 years−56.9%−97.5%
Beta (5Y)0.500.66
Employees808613
StockData Score
Total score12 (better)4
Valuation score3 (better)0
Growth score11
Performance score22
Health score6 (better)1
Dividend score00
Valuation
P/S1.5× (better)6.2×
P/B2.2× (better)32.5×
P/FCF–85.4×
FCF yield–1.2%
Fair value$5.34$3.34
Margin of safety40.4% (better)−316%
Growth
Revenue growth (TTM)−22.8%−6.5% (better)
Revenue growth, 5Y average11.0%20.4% (better)
Net income growth (TTM)−147%–
EPS growth (TTM)−148%–
Profitability
Gross margin77.3% (better)66.4%
Operating margin−8.3%−1.5% (better)
Net margin−6.3% (better)−9.8%
FCF margin–7.3%
Return on equity−8.5% (better)−43.9%
Return on invested capital−19.3%–
Financial health
Debt / equity0.00–
Interest coverage–−0.2×
Current ratio4.35 (better)1.76
Altman Z-score6.29 (better)1.88
Piotroski F-score67 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions79.9%2.6%
Held by insiders2.9%43.3%
Insider net buying, 12 months$0–
Short interest, % of float6.3%0.49%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.